“Our findings suggest that the αSyn-SAA technique is highly accurate at detecting the biomarker for Parkinson’s disease regardless of the clinical features," says Luis Concha, Ph.D., "making it possible to accurately diagnose the disease in patients at early stages.” For those in the Parkinson's Disease community, this is a big-deal, “game-changing” report.
